Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström’s Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study

ADVANCES IN THERAPY（2024）

引用 0|浏览11

暂无评分

摘要

Waldenström’s macroglobulinemia (WM) is a rare malignant B cell lymphoma which occurs in around 1–2

查看译文

关键词

Ibrutinib,Chinese patients,Waldenström’s macroglobulinemia,Safety,Efficacy,Pharmacokinetics,Relapsed/refractory

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要